Endovascular brachytherapy combined with portal vein stenting and transarterial chemoembolization improves overall survival of hepatocellular carcinoma patients with main portal vein tumor thrombus.
作者:
主题词
成年人(Adult);老年人(Aged);近距离放射疗法(Brachytherapy);癌, 肝细胞(Carcinoma, Hepatocellular);化学栓塞, 治疗性(Chemoembolization, Therapeutic);综合疗法(Combined Modality Therapy);无病生存(Disease-Free Survival);女(雌)性(Female);人类(Humans);Kaplan-Meiers评估(Kaplan-Meier Estimate);肝肿瘤(Liver Neoplasms);男(雄)性(Male);中年人(Middle Aged);多元分析(Multivariate Analysis);门静脉(Portal Vein);回顾性研究(Retrospective Studies);支架(Stents);治疗结果(Treatment Outcome);静脉血栓形成(Venous Thrombosis)
DOI
10.18632/oncotarget.14520
PMID
28076848
发布时间
2022-03-11
- 浏览14

Oncotarget
12108-12119页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文